Federal Register Notice: FDA intends to accept and consider a single source application for awarding a cooperative agreement to the World Health Organization (WHO) in support of collaboration in regulatory science and capacity of National Regulatory Authorities (NRAs) to advance global access to safe and effective vaccines and other biologics that meet international standards. The goal of FDA’s CBER is to enhance technical collaboration and cooperation between FDA, WHO, and its member states. To view this notice, click here.